As of July 2025 Ardelyx has a market cap of ยฃ0.75 Billion. This makes Ardelyx the world's 5869th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | ยฃ0.75 B | -23.12% |
2024 | ยฃ0.98 B | -12.96% |
2023 | ยฃ1.12 B | 155.82% |
2022 | ยฃ0.44 B | 380.66% |
2021 | ยฃ91.87 M | -79.32% |
2020 | ยฃ0.44 B | -12.6% |
2019 | ยฃ0.50 B | 476.61% |
2018 | ยฃ88.15 M | -62.02% |
2017 | ยฃ0.23 B | -57.36% |
2016 | ยฃ0.54 B | 71.46% |
2015 | ยฃ0.31 B | 40.76% |
2014 | ยฃ0.22 B |
On Jul 29th, 2025 the market cap of Ardelyx was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() OPKO Health
OPK | ยฃ0.80 B | 6.04% | ๐บ๐ธ USA |
![]() Amgen AMGN | ยฃ122.22 B | 16,066.50% | ๐บ๐ธ USA |
![]() Sanofi SNY | ยฃ90.94 B | 11,928.59% | ๐ซ๐ท France |
![]() Abbott Laboratories ABT | ยฃ166.77 B | 21,958.69% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | ยฃ174.45 B | 22,975.19% | ๐ฌ๐ง UK |